Updated Guidance by the CDC and FDA for Prescribing Opioids – June 2023

Maximize the use of nonopioid therapies when possible and only consider opioids if the benefits of therapy are expected to outweigh the risks. Many nonopioid therapies (including nonpharmacological interventions) are at least as effective as opioids for common types of acute pain. Before starting opioids for pain, establish realistic treatment goals and discuss a plan [...]

Read more

Clinical Review: Management of Acute Postpartum Pain

Racial and ethnic disparities are prevalent in maternal care, and improving health equity has been identified as a priority focus for the Medi-Cal program. ACOG recommends shared decision-making using a stepwise, multimodal approach that includes acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) as first-line analgesics, especially for individuals who are breastfeeding. If first-line options do not [...]

Read more

Improving the Quality of Care: Treatment of Latent Tuberculosis Infection

Describe populations at high risk for infection with Mycobacterium tuberculosis (M. tuberculosis) and for developing tuberculosis (TB) disease once infected. Explain the different testing options for diagnosing latent tuberculosis infection (LTBI), as well as their advantages and limitations. Summarize the 2020 guidelines for the treatment of LTBI recommended by the National Tuberculosis Controllers Association and [...]

Read more

2022 Immunization Update: Mpox, HepB, Influenza, COVID-19, Pneumococcal, Zoster

Each year, the California Medi-Cal Drug Use Review (DUR) program issues an annual summary of updates on immunization guidelines, products, and/or research in collaboration with the California Department of Public Health (CDPH) Immunization Branch. For reference, the recommended immunization schedules for 2022 in the United States can be accessed on the Centers for Disease Control [...]

Read more

1 2 3 9
top
X